An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

PHASE3CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

June 30, 2008

Conditions
Attention Deficit Hyperactivity DisorderAttention Deficit Disorders With HyperactivityAttention Deficit Hyperactivity Disorders
Interventions
DRUG

Vyvanse (lisdexamfetamine dimesylate), NRP104

NRP104 capsule once-a-day orally beginning at 30mg/day and titrated by 20 mg per day at weekly intervals up to a maximum daily dose of 70 mg

Trial Locations (45)

10010

VA New York Harbor Healthcare System, New York

19149

CNS Research Institute, P.C., Philadelphia

20170

NeuroScience, Inc., Herndon

20852

Marc Hertzman, MD, Rockville

21093

Johns Hopkins at Green Spring Station, Lutherville

22903

Psychiatric Alliance of the Blue Ridge Clinical Research, Charlottesville

23452

Brighton Research Group, Virginia Beach

27609

Richard Weisler and Associates, Raleigh

27705

Duke University ADHD Program, Durham

30076

Northwest Behavioral Research Center, Roswell

30080

Carman Research, Smyrna

32806

Clinical Neuroscience Solutions, Inc., Orlando

33173

Miami Research Associates, Miami

33407

Janus Center for Psychiatric Research LLC, West Palm Beach

33606

Meridien Research, Tampa

33912

Gulfcoast Clinical Research Center, Fort Myers

43210

The Ohio State University, Columbus

48307

Rochester Center for Behavioral Medicine, Rochester Hills

48507

Summit Research Network (Michigan) Inc., Flint

63301

St Charles Psychiatric Associates-Midwest Research, Saint Charles

66211

Psychiatric Associates, Overland Park

66212

Vince and Associates Clinical Research, Overland Park

72205

Clinical Study Centers, LLC, Little Rock

73103

IPS Research Company, Oklahoma City

77007

Bayou City Research, Houston

77090

Red Oak Psychiatry Associates, P.A., Houston

77401

Claghorn-Lesem Research Clinic, Bellaire

77566

R/D Clinical Research, Inc., Lake Jackson

78756

FutureSearch Trials, Austin

79423

John M. Turnbow, MD, PA, Lubbock

80304

Alpine Clinical Research Center, Boulder

89128

Center for Psychiatry and Behavioral Medicine, Las Vegas

90274

Peninsula Research Associates, Rolling Hills Estate

91978

Encompass Clinical Research, Spring Valley

92243

Valley Clinical Research, Inc., El Centro

92612

University of California, Irvine Child Development Center, Irvine

94143

University of California, San Francisco, Dept. of Psychiatry, San Francisco

94549

Bay Area Research Institute, Lafayette

98104

Summit Research Network LLC (Seattle), Seattle

06320

Psychiatric Medicine Center, New London

02138

Masschusetts General Hospital, Cambridge

08021

CNS Research Institute (CRI), Clementon

97210-2659

Oregon Center for Clinical Investigations, Inc., Portland

05401

The Clinical Study Center, Burlington

05091

Neuropsychiatric Associates, Woodstock

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

New River Pharmaceuticals

INDUSTRY